SCHEMBL30565216

SCHEMBL30565216

COc1cc(Nc2ncc(C)c(Nc3cccc(S(=O)(=O)NC(C)(C)C)c3)n2)cc(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 9/20 0.67
▸ BRD4 O60885 12/20 0.64
▸ JAK1 P23458 8/20 0.64
▸ JAK3 P52333 7/20 0.64
▸ TYK2 P29597 4/20 0.64
▸ FLT3 P36888 4/20 0.64
▸ RET P07949 3/20 0.64
▸ WEE1 P30291 3/20 0.64
▸ ALK Q9UM73 3/20 0.64
▸ BRDT Q58F21 2/20 0.64
▸ PLK4 O00444 2/20 0.64
▸ CHEK1 O14757 2/20 0.64
▸ AURKA O14965 2/20 0.64
▸ DCLK1 O15075 2/20 0.64
▸ DAPK3 O43293 2/20 0.64
▸ ROCK2 O75116 2/20 0.64
▸ PAK4 O96013 2/20 0.64
▸ ABL1 P00519 2/20 0.64
▸ EGFR P00533 2/20 0.64
▸ NTRK1 P04629 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25381399 1.00 JAK2 (0.67) JAK2BRD4JAK1JAK3TYK2
SCHEMBL31163043 0.94 JAK2 (0.62) JAK2BRD4JAK1JAK3TYK2
SCHEMBL31163131 0.94 JAK2 (0.62) JAK2BRD4JAK1JAK3TYK2
SCHEMBL20288209 0.92 JAK2 (0.75) JAK2BRD4JAK1JAK3TYK2
SCHEMBL30565206 0.91 BRD4 (0.74) JAK2BRD4JAK1JAK3TYK2
SCHEMBL25382998 0.91 BRD4 (0.74) JAK2BRD4JAK1JAK3TYK2
SCHEMBL30565204 0.91 BRD4 (0.74) JAK2BRD4JAK1JAK3TYK2
SCHEMBL25385292 0.89 JAK1 (0.73) JAK2BRD4JAK1JAK3TYK2
SCHEMBL30565209 0.89 JAK1 (0.73) JAK2BRD4JAK1JAK3TYK2
SCHEMBL31163087 0.89 JAK2 (0.63) JAK2BRD4JAK1JAK3TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673149-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2026-01-07 — — EP disclosed
EP-4486348-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2025-01-08 — — EP disclosed
CN-118804751-A New compounds and treatment of renal cell carcinoma 巴什生物技术公司 2024-10-18 — — CN disclosed
WO-2024179699-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC. (US) 2024-09-06 — — WO disclosed
WO-2023166153-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC (US) 2023-09-07 — — WO disclosed
Send feedback